Publications by authors named "P Weynants"

Claim this Profile
C
Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.
J F Vansteenkiste, J E Vandebroek, K L Nackaerts, P Weynants, Y J Valcke

Ann Oncol· September 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus etoposide in chemonaive extensive disease small-cell lung cancer: a multi-centre phase II study.
J Vansteenkiste, U Gatzemeier, C Manegold, A Hanauske, P Weynants

Ann Oncol· June 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival.
V Karanikas, D Colau, J F Baurain, R Chiari, J Thonnard, P Weynants

Cancer Res· May 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription.
B J Van Den Eynde, B Gaugler, M Probst-Kepper, L Michaux, O Devuyst, P Weynants

J Exp Med· December 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clinique de l'Université Catholique de Louvain, Brussels and Liège, Belgium.
H van de Velde, L Bosquée, P Weynants, J L Canon, J F Rosier

Ann Oncol· September 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis